CVAC Shares Calculator
Enter either the number of shares you'd like to purchase OR the total investment you'd like to make.
shares x $2.31 = $23.1
CVAC Prices
View the CVAC historical prices.
52WL $2.22
The 52 Week Low is $2.22 set on Fri, Feb 23, 2024.
52WH $12.36
The 52 Week High is $12.36 set on Fri, Jun 23, 2023. The current price, $2.31, is 0% below the 52 Week High.
ATH $151.80
The All-Time High is $151.80 set on Wed, Dec 9, 2020. The current price, $2.31, is 0% below the All Time High.
52 Week Range
CVAC Dividends
CVAC has no dividend history.
0.00%
Annual Dividend Yield
$
Quarterly Dividend Rate
--
Declaration Date
--
Ex-Dividend Date
--
Record Date
--
Payment Date
--
Dividend Frequency
0
Dividend History
CVAC Profile
CureVac is a biopharmaceutical company headquartered in Germany that is developing vaccines and therapies using messenger ribonucleic acid (mRNA). The company was founded in 2000 and had its initial public offering in August 2020. CureVac is collaborating with GlaxoSmithKline to develop a second-generation COVID-19 vaccine. CureVac's first attempt to develop a COVID-19 vaccine did not have sufficient efficacy data, and its trials were discontinued in October 2021. The company's other pipeline candidates include mRNA vaccines for influenza, rabies, and malaria. Additionally, CureVac is in the early stages of development for oncology and molecular therapies spanning tumors, liver, ocular, and lung diseases.
